Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D0DW
|
||||
Former ID |
DNC004755
|
||||
Drug Name |
1-(4-Bromo-benzyl)-3-quinazolin-8-yl-urea
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527423] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H13BrN4O
|
||||
Canonical SMILES |
C1=CC2=CN=CN=C2C(=C1)NC(=O)NCC3=CC=C(C=C3)Br
|
||||
InChI |
1S/C16H13BrN4O/c17-13-6-4-11(5-7-13)8-19-16(22)21-14-3-1-2-12-9-18-10-20-15(12)14/h1-7,9-10H,8H2,(H2,19,21,22)
|
||||
InChIKey |
HUPXBWYDCNIXNH-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Vanilloid receptor 1 | Target Info | Inhibitor | [527423] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | ||||
Trk receptor signaling mediated by PI3K and PLC-gamma | |||||
Reactome | TRP channels | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.